ABACAVIR/LAMIVUDINA AUROVITAS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
ABACAVIR/LAMIVUDINA AUROVITAS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Commercialized
Register Number
81926
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Apr 2, 2017
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number81926
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
ABACAVIR SULFATOActive
Quantity: 702,780 mg
Name: ABACAVIR SULFATO
LAMIVUDINAActive
Quantity: 300,000 mg
Name: LAMIVUDINA
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR02